First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved – Monthly Prescribing Reference


Monthly Prescribing Reference

First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved
Monthly Prescribing Reference
Teva announced that the Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms. ProAir RespiClick is indicated for the …
FDA clears Teva asthma med (TEVA)Seeking Alpha (registration)
FDA Approves Teva's New Asthma TreatmentArutz Sheva
FDA approves ProAir RespiClick for treatment of acute asthma symptomsHealio
PharmiWeb.com (press release)
all 10 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.